Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2020-02-13 | RENAISSANCE TECHNOLOGIES LLC | GENOMIC HEALTH INC | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-11-13 | EXACT SCIENCES CORP | GENOMIC HEALTH INC | 100 | 100.0% | EDGAR |
SC 13G | 2019-11-13 | ICS OPPORTUNITIES, LTD. | GENOMIC HEALTH INC | - | 0.0% | EDGAR |
SC 13G/A | 2019-08-09 | BlackRock Inc. | GENOMIC HEALTH INC | 4,086,307 | 11.0% | EDGAR |
SC 13D | 2019-08-07 | EXACT SCIENCES CORP | GENOMIC HEALTH INC | 9,596,023 | 25.6% | EDGAR |
SC 13D/A | 2019-07-31 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 9,422,126 | 25.3% | EDGAR |
SC 13D/A | 2019-04-12 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 9,421,702 | 25.4% | EDGAR |
SC 13D/A | 2019-03-25 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 10,339,723 | 27.9% | EDGAR |
SC 13D/A | 2019-03-14 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 10,716,480 | 28.9% | EDGAR |
SC 13D/A | 2019-02-28 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 11,127,129 | 30.7% | EDGAR |
SC 13G/A | 2019-02-14 | Camber Capital Management LP | GENOMIC HEALTH INC | - | - | EDGAR |
SC 13G | 2019-02-12 | RENAISSANCE TECHNOLOGIES LLC | GENOMIC HEALTH INC | 1,947,100 | 5.4% | EDGAR |
SC 13G | 2019-02-11 | VANGUARD GROUP INC | GENOMIC HEALTH INC | 2,336,453 | 6.5% | EDGAR |
SC 13G/A | 2019-02-04 | BlackRock Inc. | GENOMIC HEALTH INC | 2,191,689 | 6.1% | EDGAR |
SC 13D/A | 2019-01-22 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 11,430,796 | 31.5% | EDGAR |
SC 13D/A | 2018-12-03 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 12,206,370 | 33.7% | EDGAR |
SC 13D/A | 2018-11-28 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 12,664,539 | 34.9% | EDGAR |
SC 13D/A | 2018-11-13 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 13,180,611 | 36.3% | EDGAR |
SC 13D/A | 2018-03-12 | BAKER BROS. ADVISORS LP | GENOMIC HEALTH INC | 13,918,966 | 39.9% | EDGAR |
SC 13G/A | 2018-01-25 | BlackRock Inc. | GENOMIC HEALTH INC | 1,948,830 | 5.6% | EDGAR |